The Effect of Oral Semaglutide on Bone Turnover in Patients With T2D: a Randomized Placebo-controlled Clinical Trial
The Effect of Oral Semaglutide on Bone Turnover in Patients With T2D: a Randomized Placebo-controlled Clinical Trial
Active, not recruiting · NCT06050577 · Registry updated 2026-10-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The Effect of Oral Semaglutide on Bone Turnover in Patients With T2D: a Randomized Placebo-controlled Clinical Trial | Bone Diseases, Metabolic, Nutritional and Metabolic Diseases, Osteopenia, bone disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, musculoskeletal system disorder, type 2 diabetes mellitus | Active, not recruiting | Phase 2 | 2026-10-05 | NCT06050577 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Odense University Hospital | 253 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Odense University Hospital | Odense | Denmark | 97 |